Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar 15;90(6):2380-4.
doi: 10.1073/pnas.90.6.2380.

Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide

E Ferrero  1 , D Jiao, B Z Tsuberi, L Tesio, G W Rong, A Haziot, S M Goyert
Affiliations

Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide

E Ferrero et al. Proc Natl Acad Sci U S A. .

Abstract

In vitro studies have previously shown that the myelomonocytic differentiation antigen CD14 is a receptor for a complex consisting of lipopolysaccharide (LPS) and LPS-binding protein. To investigate the role of CD14 in vivo and its relationship to induction of LPS-induced endotoxin shock, transgenic mice expressing human CD14 were produced. These mice express human CD14 strongly on the surface of their monocytes, neutrophils, and Thy-1(+) lymphocytes and are hypersensitive to LPS, as evidenced by their increased susceptibility to endotoxin shock. These results document the importance of CD14 in vivo as a primary mediator of this lethal syndrome. Furthermore, these mice provide an important model for testing the therapeutic effects of agents directed specifically against the human, as opposed to the murine, CD14 protein in preventing LPS-induced endotoxin shock.

PubMed Disclaimer

References

    1. J Immunol. 1981 Apr;126(4):1435-42 - PubMed
    1. J Biol Chem. 1992 Apr 25;267(12):8599-603 - PubMed
    1. Nature. 1981 Oct 15-21;293(5833):543-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5374-8 - PubMed
    1. Methods Enzymol. 1983;101:411-33 - PubMed

Publication types

MeSH terms

Substances